Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
SEC Accession No. 0001193125-24-021090
Filing Date
2024-01-31
Accepted
2024-01-31 17:25:31
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC TO-I/A d729281dsctoia.htm SC TO-I/A 39952
2 EX-(A)(1)(K) d729281dex99a1k.htm EX-99.(A)(1)(K) 4517
  Complete submission text file 0001193125-24-021090.txt   46061
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filed by) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Subject) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I/A | Act: 34 | File No.: 005-88275 | Film No.: 24584017
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)